Back to top
more

Cara Therapeutics (CARA)

(Delayed Data from NSDQ)

$0.35 USD

0.35
1,091,221

-0.01 (-3.61%)

Updated Jul 12, 2024 04:00 PM ET

After-Market: $0.34 -0.01 (-3.63%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of -4.00% and 359.84%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More

    Key headlines in the biotech sector last week include Gilead getting positive CHMP opinion, Keryx plunging on merger news while Celgene and Amgen came out with pipeline updates.

      Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options

      Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.

        Surging Earnings Estimates Signal Good News for Cara Therapeutics (CARA)

        Cara Therapeutics (CARA) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.

          Megan Sanks headshot

          Here's Why Cara Therapeutics (CARA) Shares Plummeted 31% Today

          Shares of Cara Therapeutics (CARA) nosedived 31% Friday in morning trading after the company announced disappointing results on the CR845 oral medication from a phase 2b trial.

            Cara Therapeutics (CARA) Shows Strength: Stock Adds 12.2 % in Session

            Cara Therapeutics, Inc. (CARA) was a big mover last session, as the company saw its shares rise over 12% on the day

              Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options

              Investors in Cara Therapeutics (CARA) need to pay close attention to the stock based on moves in the options market lately.

                Megan Sanks headshot

                Cara Therapeutics (CARA) Stock Rises After Cr845 Trial Update

                Cara Therapeutics, Inc. (CARA) shares gained 10% in late morning trading following the recent evaluation of its trial for Cr845.

                  Sweta Killa headshot

                  5 Top Performing Stocks of the Best ETF of Q1

                  Inside the top performing stocks of biotech ETF that tops the list of the best performing ETFs of Q1.

                    Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2%

                    Cara Therapeutics, Inc. (CARA) shares rose above 5% in the last trading session.

                      Are Options Traders Betting on a Big Move in Cara Therapeutics, Inc. (CARA) Stock?

                      Investors in Cara Therapeutics, Inc. (CARA) need to pay close attention to the stock as it has some of the highest implied volatility of all equity options today.

                        Cara Therapeutics (CARA) Worth Watching: Stock Jumps 8%

                        Cara Therapeutics, Inc. (CARA) was a big mover last session, as the company saw its shares climb over 8% on the day.